|
| related topics |
| {product, liability, claim} |
| {product, market, service} |
| {stock, price, share} |
| {property, intellectual, protect} |
| {provision, law, control} |
| {stock, price, operating} |
| {customer, product, revenue} |
| {acquisition, growth, future} |
|
|
If we cannot meet international product standards, we will be unable to distribute our products outside of the United States, which could cause our business to suffer.
If the healthcare industry limits coverage or reimbursement levels, the acceptance of our products could suffer.
We depend on outside suppliers for manufacturing.
If we are unable to manage our growth, our results of operations could suffer.
We may be unable to compete in the medical equipment field, which could cause our business to fail.
We are dependent on a single technology, and if it cannot compete or find market acceptance, our business will suffer.
We rely on patents and proprietary rights to protect our technology.
If our products fail or cause harm, we could be subject to substantial product liability, which could cause our business to suffer.
There are a large number of shares eligible for sale into the public market in the near future, which may reduce the price of our common stock.
Our stock price may be highly volatile, which increases the risk of securities litigation.
Concentration of ownership could delay or prevent a change in control or otherwise influence or control most matters submitted to our shareholders.
Full 10-K form ▸
|
|
| related documents |
| 882873--9/21/2009--UROLOGIX_INC |
| 943894--3/28/2008--EZENIA_INC |
| 718924--12/27/2006--SPAN_AMERICA_MEDICAL_SYSTEMS_INC |
| 739944--3/11/2008--MEDTOX_SCIENTIFIC_INC |
| 1006195--3/15/2007--MATRIXX_INITIATIVES_INC |
| 894237--6/29/2006--VISION_SCIENCES_INC_/DE/ |
| 739944--3/15/2007--MEDTOX_SCIENTIFIC_INC |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 862668--9/29/2008--ESCALON_MEDICAL_CORP |
| 739944--3/17/2006--MEDTOX_SCIENTIFIC_INC |
| 874734--3/8/2010--OSTEOTECH_INC |
| 780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 1050007--11/30/2006--NUTRACEUTICAL_INTERNATIONAL_CORP |
| 764579--3/19/2008--CAS_MEDICAL_SYSTEMS_INC |
| 862668--10/12/2010--ESCALON_MEDICAL_CORP |
| 57528--2/22/2008--LANCE_INC |
| 768408--6/24/2010--CYANOTECH_CORP |
| 880432--9/28/2009--MISONIX_INC |
| 739944--3/10/2009--MEDTOX_SCIENTIFIC_INC |
| 882873--9/17/2010--UROLOGIX_INC |
| 882873--9/29/2008--UROLOGIX_INC |
| 27096--9/12/2007--DATASCOPE_CORP |
| 943894--3/31/2010--EZENIA_INC |
| 771252--3/8/2006--DIGITAL_ANGEL_CORP |
| 811669--2/24/2006--UST_INC |
| 10456--2/26/2008--BAXTER_INTERNATIONAL_INC |
| 780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 1000736--3/2/2006--CAREMARK_RX_INC |
| 1005010--3/24/2006--ARTHROCARE_CORP |
| 874710--9/28/2006--ALLIED_HEALTHCARE_PRODUCTS_INC |
|